CVS Health First-Quarter Earnings Surge Driven by Aetna's Performance
CVS Health reported a robust increase in its first-quarter earnings, driven largely by Aetna's performance in the Health Care Benefits Segment, which saw a 12.5% rise in adjusted operating income. This segment's income climbed to $3.04 billion from $1.99 billion in the prior year. The growth was attributed to improved results from government-sponsored programs, including Medicare Advantage, Medicare Supplement plans, and managed Medicaid services.
Despite this financial boost, CVS Health experienced a decrease in medical membership, dropping to 26 million from 27.1 million due to its decision to exit the individual exchange market by 2026. The financial landscape for Medicare Advantage plans improved as the Centers for Medicare and Medicaid Services (CMS) announced a 2.48% rate hike for 2027, a significant increase from the initial 0.09% proposed, potentially boosting insurer payments by over $13 billion, as estimated by CMS.
Aetna has reported significant advancements in its prior authorization processes, with more than 95% of eligible requests approved within 24 hours and 83% processed in real time. This initiative has reduced over 1 million provider calls through enhanced automation and digital tools, aligning with AHIP's push for standardized electronic prior authorization in services such as orthopedic surgeries and imaging.
CVS Health has launched a new health technology services unit, Health100, in collaboration with Google Cloud. This venture seeks to improve interoperability across the healthcare spectrum, enhancing efficiency and connectivity between providers and payers.
Financially, CVS Health's adjusted operating income for Q1 rose to $5.15 billion, improving from $4.58 billion in the previous year's same quarter. This increase was partly due to the absence of a $387 million litigation charge and a $247 million pre-tax loss related to the sale of certain healthcare assets recorded last year. The company's revenue grew by 6.2% in this period.
While the Health Care Benefits segment's revenue increased to $36 billion from $35.8 billion, the Pharmacy and Consumer Wellness segment faced a decline in adjusted operating income due to reimbursement challenges, business investments, and weather-related disruptions. However, these were partially offset by higher prescription volumes and gains from the Rite Aid acquisition.
The Health Services business reported a decline in operating income, influenced by improved pharmacy client pricing being offset by better purchasing economics and a varied pharmacy drug mix. J. David Joyner, CVS Health's CEO, emphasized the company's commitment to enhancing accessibility, affordability, and care quality for its 185 million customers, reinforcing its strategy to simplify healthcare.